Lv11
50 积分 2026-03-09 加入
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species
7天前
已完结
https://pubs.acs.org/doi/10.1021/acsmedchemlett.3c00001
8天前
已完结